Sage Capital Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,400
| Closed | -$111K | – | 142 |
|
|
2024
Q3 | $111K | Hold |
10,400
| – | – | 0.03% | 138 |
|
|
2024
Q2 | $103K | Buy |
+10,400
| New | +$103K | 0.03% | 133 |
|
|
2023
Q1 | – | Sell |
-10,800
| Closed | -$132K | – | 133 |
|
|
2022
Q4 | $132K | Hold |
10,800
| – | – | 0.06% | 126 |
|
|
2022
Q3 | $113K | Sell |
10,800
-600
| -5% | -$6.28K | 0.06% | 116 |
|
|
2022
Q2 | $122K | Sell |
11,400
-450
| -4% | -$4.82K | 0.06% | 102 |
|
|
2022
Q1 | $103K | Buy |
+11,850
| New | +$103K | 0.04% | 105 |
|
|
2021
Q4 | – | Sell |
-10,850
| Closed | -$104K | – | 109 |
|
|
2021
Q3 | $104K | Buy |
+10,850
| New | +$104K | 0.04% | 104 |
|
|
2020
Q1 | – | Sell |
-10,200
| Closed | -$99K | – | 103 |
|
|
2019
Q4 | $99K | Buy |
+10,200
| New | +$99K | 0.06% | 97 |
|
|
2019
Q3 | – | Sell |
-10,200
| Closed | -$135K | – | 97 |
|
|
2019
Q2 | $135K | Sell |
10,200
-2,000
| -16% | -$26.5K | 0.09% | 89 |
|
|
2019
Q1 | $166K | Sell |
12,200
-200
| -2% | -$2.72K | 0.11% | 87 |
|
|
2018
Q4 | $119K | Buy |
12,400
+1,500
| +14% | +$14.4K | 0.09% | 81 |
|
|
2018
Q3 | $132K | Buy |
10,900
+700
| +7% | +$8.48K | 0.08% | 85 |
|
|
2018
Q2 | $159K | Sell |
10,200
-500
| -5% | -$7.79K | 0.11% | 84 |
|
|
2018
Q1 | $161K | Sell |
10,700
-500
| -4% | -$7.52K | 0.11% | 82 |
|
|
2017
Q4 | $161K | Buy |
11,200
+1,000
| +10% | +$14.4K | 0.1% | 81 |
|
|
2017
Q3 | $154K | Buy |
+10,200
| New | +$154K | 0.11% | 81 |
|